Aller au contenu principal
2025 article

Biogenic Polymers for Congenital Cardiac Surgery: In Vitro Durability Testing

1Citations signalées, ce qui n’est pas une note de qualité
8Institutions déclarées
3Pays d’affiliation déclarés

Rattachement africain : de, be, ch. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

OBJECTIVES: Currently available materials in congenital cardiac surgery (CCS) are far from optimal because they do not facilitate growth, remodelling, or renewal, resulting in poorer long-term outcomes due to material-related limitations. Bacterial cellulose (BC), a biogenic polymer-based material produced by Acetobacter xylinum, has emerged as a promising alternative exhibiting excellent bio- and haemocompatibility. This study aimed to develop BC specifically for application in CCS by modifying culturing conditions to enhance its biomechanical resilience. METHODS: Bacterial cellulose was produced according to a standard protocol, and its biomechanical properties were evaluated using inflation pressure testing, thickness measurement, and uniaxial tensile testing. To improve these characteristics, 2 modifications, a change in the growth media composition and an extended incubation time, were implemented and subsequently evaluated in 5 further test series. The long-term durability of BC patches was assessed in a fatigue tester for 20 ± 0.5 million cycles, and potential structural damage was investigated using scanning electron microscopy. RESULTS: Utilizing the 2 modifications, BC patches demonstrated a capability to reach and maintain pressures exceeding 1000 mm Hg with a durability of 100% (n = 24), compared to the standard 20.8% (n = 24) at 500 mm Hg. The maximum tensile strength was enhanced from 0.311 ± 0.057 megapascal (MPa) to 0.986 ± 0.397 MPa (P < .0001), with a thickness of 3.89 ± 0.95 mm (P < .0001). In the long-term durability testing, patches endured durations equalling 6 months without failure while retaining structural integrity. CONCLUSIONS: The potential of BC for use in CCS was demonstrated by enhancing its biomechanical properties through culturing modifications, warranting further investigation and development of the biomaterial.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Biogenic Polymers for Congenital Cardiac Surgery: In Vitro Durability Testing
Date Crossref
23/09/2025
Éditeur
Oxford University Press (OUP)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Hemostasis and retained surgical itemsTissue Engineering and Regenerative MedicineAdvanced Cellulose Research Studies

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.